Customer Center

Samyang News

Samyang News
Samyang Biopharmaceuticals invited 9 Key Oncology Doctors from India to a seminar held from April 25th ~ 28th. Print
Affiliates Samyang Biopharm Writer administrator Hits 822 Date 2018.04.25

 

 

Samyang Biopharmaceuticals’ Overseas Business Team and Indian partner Lupin held the event to expand and share Samyang’s proprietary technology and capabilities. The seminar consisted of exchange of participants’ clinical experience as well as Samyang’s oncology products, a tour of Samyang’s EU-GMP pharmaceutical plant and Samyang Discovery Center, and presentation of Samyang’s Genexol-PM by Professor Sohn from Yonsei Severance Hospital. The contents emphasized Samyang’s high-quality GMP status raising awareness of its trademark lyophilized injectable, Genexol-PM.

이전 다음글 제목을 나타낸 표
Prev Samyang Biopharmaceutical Corp. Presents “The Cases of Formulation Changes of Lenalidomide “ 2018.04.26
Next Samyang Biopharmaceuticals Corp. Invited Foreign Cancer Specialist and Held a Seminar 2018.04.09